+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Paper Diagnostics - Global Strategic Business Report

  • PDF Icon

    Report

  • 174 Pages
  • December 2024
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 5140084
The global market for Paper Diagnostics was estimated at US$8.8 Billion in 2023 and is projected to reach US$13.8 Billion by 2030, growing at a CAGR of 6.6% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

Global Paper Diagnostics Market - Key Trends & Drivers Summarized

What Are Paper Diagnostics and Why Are They Gaining Traction in Healthcare?

Paper diagnostics refers to the use of paper-based devices for medical testing and disease detection. These devices are typically made from cellulose or other porous materials that are inexpensive, easy to use, and disposable. Paper diagnostics has gained popularity, particularly in resource-limited settings, as they provide a cost-effective alternative to traditional laboratory-based tests. They are often used in lateral flow assays, such as pregnancy tests or rapid diagnostic tests for infectious diseases like malaria, COVID-19, or HIV. The simplicity and portability of these devices make them ideal for point-of-care testing, where timely diagnosis is crucial. In addition, paper diagnostics are environmentally friendly, being biodegradable and requiring minimal reagents or equipment for operation.

How Are Technological Advancements Enhancing the Capabilities of Paper Diagnostics?

Technological advancements have greatly expanded the applications of paper diagnostics. Innovations in microfluidics, where small volumes of fluids are directed through channels etched into paper, have made it possible to develop more complex diagnostics that can perform multiple tests simultaneously. The incorporation of colorimetric, electrochemical, and fluorescent detection methods into paper diagnostics has improved their sensitivity and accuracy, allowing for more reliable results. In addition, the development of paper-based biosensors, which can detect specific biomarkers in blood, saliva, or urine, is making paper diagnostics a powerful tool for early disease detection and monitoring. These advancements have opened up new possibilities for personalized healthcare, allowing individuals to perform diagnostic tests at home and receive instant results without the need for a laboratory.

How Are Global Health Initiatives and Remote Healthcare Trends Shaping the Market?

Technological innovations are transforming the paper diagnostics industry, primarily through advancements in microfluidics, biosensors, and detection methods. Microfluidics has allowed the development of devices that can handle complex assays on a small, portable paper platform. These advancements enable the creation of devices that can simultaneously conduct multiple tests, significantly improving the versatility of paper diagnostics. Moreover, the use of biosensors embedded in paper diagnostics has expanded the range of detectable conditions, from infectious diseases to chronic illnesses like diabetes. The integration of colorimetric, fluorescent, and electrochemical detection techniques further improves the accuracy and reliability of these tests, enhancing their appeal in both developed and developing markets. These technological breakthroughs make it possible to design affordable, portable diagnostic tools that can be used in low-resource settings and provide quick, reliable results at the point of care.

What Is Driving Growth in the Paper Diagnostics Market?

The demand for paper diagnostics is heavily influenced by global health initiatives that focus on improving healthcare access in remote and underserved regions. Organizations such as the World Health Organization (WHO) and NGOs are increasingly advocating for affordable diagnostic tools that can be used in areas with limited medical infrastructure. Paper diagnostics, being low-cost and easy to transport, are well-suited to these environments, where traditional laboratory tests may be inaccessible or unaffordable. These tools are crucial for the timely detection of diseases like malaria, tuberculosis, and HIV, helping to curb the spread of infectious diseases. Additionally, the COVID-19 pandemic highlighted the importance of at-home testing and telemedicine, accelerating the adoption of paper diagnostics. 

The increasing demand for point-of-care diagnostics, particularly in regions with limited access to healthcare infrastructure, has fueled the adoption of paper-based diagnostic devices. Technological advancements in microfluidics, biosensors, and detection methods have significantly improved the sensitivity, accuracy, and range of tests that can be performed on paper-based platforms. Furthermore, the global push for affordable and sustainable healthcare solutions has increased demand for paper diagnostics, which are cost-effective, portable, and environmentally friendly. The shift toward remote healthcare and personalized medicine, as well as the rising prevalence of infectious diseases and chronic conditions, are also contributing to market growth. As governments, NGOs, and healthcare organizations continue to invest in improving healthcare access, particularly in low-resource settings, the paper diagnostics market is expected to expand significantly.

Key Insights:

  • Market Growth: Understand the significant growth trajectory of the Lateral Flow Assay Kits segment, which is expected to reach US$6.7 Billion by 2030 with a CAGR of a 6.2%. The Dipsticks segment is also set to grow at 7.4% CAGR over the analysis period.
  • Regional Analysis: Gain insights into the U.S. market, estimated at $2.4 Billion in 2023, and China, forecasted to grow at an impressive 6.2% CAGR to reach $2.2 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Report Features:

  • Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
  • In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
  • Company Profiles: Coverage of major players such as Abcam PLC, Abingdon Health Ltd., Acon Laboratories, Inc., and more.
  • Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Key Questions Answered:

  • How is the Global Paper Diagnostics Market expected to evolve by 2030?
  • What are the main drivers and restraints affecting the market?
  • Which market segments will grow the most over the forecast period?
  • How will market shares for different regions and segments change by 2030?
  • Who are the leading players in the market, and what are their prospects?

Why You Should Buy This Report:

  • Detailed Market Analysis: Access a thorough analysis of the Global Paper Diagnostics Market, covering all major geographic regions and market segments.
  • Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
  • Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Paper Diagnostics Market.
  • Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Select Competitors (Total 44 Featured):

  • Abcam PLC
  • Abingdon Health Ltd.
  • Acon Laboratories, Inc.
  • Alere, Inc.
  • Arkray, Inc.
  • BBI Solutions
  • Bioporto Diagnostics A/S
  • Bio-Rad Laboratories, Inc.
  • Chembio Diagnostic Systems, Inc.
  • Cytodiagnostics Inc.
  • DCN Diagnostics
  • MilliporeSigma
  • NanoHybrids
  • SD Biosensor, Inc.
  • Siemens Healthineers
  • SurModics, Inc.

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Global Economic Update
  • Paper Diagnostics - Global Key Competitors Percentage Market Share in 2024 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
  • Rising Demand for Low-Cost, Point-of-Care Testing Drives Growth in the Paper Diagnostics Market
  • Increasing Focus on Infectious Disease Testing Expands Market Opportunities for Paper-Based Diagnostic Tools
  • Technological Advancements in Microfluidics and Biosensors Enhance the Sensitivity and Accuracy of Paper Diagnostics
  • Growing Popularity of Home Testing Solutions Fuels Demand for User-Friendly, Disposable Paper Diagnostics
  • Rising Consumer Interest in Personalized Medicine and At-Home Diagnostics Strengthens the Business Case for Paper Diagnostics
  • Technological Innovations in Colorimetric and Electrochemical Detection Methods Improve the Accuracy of Paper-Based Tests
  • Growing Need for Rapid Testing During Public Health Crises Fuels Demand for Scalable Paper Diagnostics
  • Increasing Use of Paper Diagnostics in Disease Monitoring and Management Expands Market Potential in Chronic Disease Segments
  • Rising Focus on Sustainability and Biodegradability in Medical Devices Drives Adoption of Paper-Based Diagnostic Solutions
  • Technological Innovations in Immunoassay and Lateral Flow Techniques Enhance the Versatility and Speed of Paper Diagnostics
  • Growing Adoption of Paper Diagnostics in Remote and Resource-Limited Regions Strengthens Global Healthcare Access
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Paper Diagnostics Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
  • Table 2: World Recent Past, Current & Future Analysis for Paper Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 3: World Historic Review for Paper Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 4: World 16-Year Perspective for Paper Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
  • Table 5: World Recent Past, Current & Future Analysis for Lateral Flow Assay Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 6: World Historic Review for Lateral Flow Assay Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 7: World 16-Year Perspective for Lateral Flow Assay Kits by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • Table 8: World Recent Past, Current & Future Analysis for Dipsticks by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 9: World Historic Review for Dipsticks by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 10: World 16-Year Perspective for Dipsticks by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • Table 11: World Recent Past, Current & Future Analysis for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 12: World Historic Review for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 13: World 16-Year Perspective for Other Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • Table 14: World Recent Past, Current & Future Analysis for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 15: World Historic Review for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 16: World 16-Year Perspective for Hospitals & Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • Table 17: World Recent Past, Current & Future Analysis for Home Healthcare by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 18: World Historic Review for Home Healthcare by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 19: World 16-Year Perspective for Home Healthcare by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • Table 20: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 21: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 22: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
III. MARKET ANALYSIS
UNITED STATES
  • Paper Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
  • Table 23: USA Recent Past, Current & Future Analysis for Paper Diagnostics by Product - Lateral Flow Assay Kits, Dipsticks and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 24: USA Historic Review for Paper Diagnostics by Product - Lateral Flow Assay Kits, Dipsticks and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 25: USA 16-Year Perspective for Paper Diagnostics by Product - Percentage Breakdown of Value Sales for Lateral Flow Assay Kits, Dipsticks and Other Products for the Years 2014, 2024 & 2030
  • Table 26: USA Recent Past, Current & Future Analysis for Paper Diagnostics by End-Use - Hospitals & Clinics, Home Healthcare and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 27: USA Historic Review for Paper Diagnostics by End-Use - Hospitals & Clinics, Home Healthcare and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 28: USA 16-Year Perspective for Paper Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Healthcare and Other End-Uses for the Years 2014, 2024 & 2030
CANADA
  • Table 29: Canada Recent Past, Current & Future Analysis for Paper Diagnostics by Product - Lateral Flow Assay Kits, Dipsticks and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 30: Canada Historic Review for Paper Diagnostics by Product - Lateral Flow Assay Kits, Dipsticks and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 31: Canada 16-Year Perspective for Paper Diagnostics by Product - Percentage Breakdown of Value Sales for Lateral Flow Assay Kits, Dipsticks and Other Products for the Years 2014, 2024 & 2030
  • Table 32: Canada Recent Past, Current & Future Analysis for Paper Diagnostics by End-Use - Hospitals & Clinics, Home Healthcare and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 33: Canada Historic Review for Paper Diagnostics by End-Use - Hospitals & Clinics, Home Healthcare and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 34: Canada 16-Year Perspective for Paper Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Healthcare and Other End-Uses for the Years 2014, 2024 & 2030
JAPAN
  • Paper Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
  • Table 35: Japan Recent Past, Current & Future Analysis for Paper Diagnostics by Product - Lateral Flow Assay Kits, Dipsticks and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 36: Japan Historic Review for Paper Diagnostics by Product - Lateral Flow Assay Kits, Dipsticks and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 37: Japan 16-Year Perspective for Paper Diagnostics by Product - Percentage Breakdown of Value Sales for Lateral Flow Assay Kits, Dipsticks and Other Products for the Years 2014, 2024 & 2030
  • Table 38: Japan Recent Past, Current & Future Analysis for Paper Diagnostics by End-Use - Hospitals & Clinics, Home Healthcare and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 39: Japan Historic Review for Paper Diagnostics by End-Use - Hospitals & Clinics, Home Healthcare and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 40: Japan 16-Year Perspective for Paper Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Healthcare and Other End-Uses for the Years 2014, 2024 & 2030
CHINA
  • Paper Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
  • Table 41: China Recent Past, Current & Future Analysis for Paper Diagnostics by Product - Lateral Flow Assay Kits, Dipsticks and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 42: China Historic Review for Paper Diagnostics by Product - Lateral Flow Assay Kits, Dipsticks and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 43: China 16-Year Perspective for Paper Diagnostics by Product - Percentage Breakdown of Value Sales for Lateral Flow Assay Kits, Dipsticks and Other Products for the Years 2014, 2024 & 2030
  • Table 44: China Recent Past, Current & Future Analysis for Paper Diagnostics by End-Use - Hospitals & Clinics, Home Healthcare and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 45: China Historic Review for Paper Diagnostics by End-Use - Hospitals & Clinics, Home Healthcare and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 46: China 16-Year Perspective for Paper Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Healthcare and Other End-Uses for the Years 2014, 2024 & 2030
EUROPE
  • Paper Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
  • Table 47: Europe Recent Past, Current & Future Analysis for Paper Diagnostics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 48: Europe Historic Review for Paper Diagnostics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 49: Europe 16-Year Perspective for Paper Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
  • Table 50: Europe Recent Past, Current & Future Analysis for Paper Diagnostics by Product - Lateral Flow Assay Kits, Dipsticks and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 51: Europe Historic Review for Paper Diagnostics by Product - Lateral Flow Assay Kits, Dipsticks and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 52: Europe 16-Year Perspective for Paper Diagnostics by Product - Percentage Breakdown of Value Sales for Lateral Flow Assay Kits, Dipsticks and Other Products for the Years 2014, 2024 & 2030
  • Table 53: Europe Recent Past, Current & Future Analysis for Paper Diagnostics by End-Use - Hospitals & Clinics, Home Healthcare and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 54: Europe Historic Review for Paper Diagnostics by End-Use - Hospitals & Clinics, Home Healthcare and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 55: Europe 16-Year Perspective for Paper Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Healthcare and Other End-Uses for the Years 2014, 2024 & 2030
FRANCE
  • Paper Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
  • Table 56: France Recent Past, Current & Future Analysis for Paper Diagnostics by Product - Lateral Flow Assay Kits, Dipsticks and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 57: France Historic Review for Paper Diagnostics by Product - Lateral Flow Assay Kits, Dipsticks and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 58: France 16-Year Perspective for Paper Diagnostics by Product - Percentage Breakdown of Value Sales for Lateral Flow Assay Kits, Dipsticks and Other Products for the Years 2014, 2024 & 2030
  • Table 59: France Recent Past, Current & Future Analysis for Paper Diagnostics by End-Use - Hospitals & Clinics, Home Healthcare and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 60: France Historic Review for Paper Diagnostics by End-Use - Hospitals & Clinics, Home Healthcare and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 61: France 16-Year Perspective for Paper Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Healthcare and Other End-Uses for the Years 2014, 2024 & 2030
GERMANY
  • Paper Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
  • Table 62: Germany Recent Past, Current & Future Analysis for Paper Diagnostics by Product - Lateral Flow Assay Kits, Dipsticks and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 63: Germany Historic Review for Paper Diagnostics by Product - Lateral Flow Assay Kits, Dipsticks and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 64: Germany 16-Year Perspective for Paper Diagnostics by Product - Percentage Breakdown of Value Sales for Lateral Flow Assay Kits, Dipsticks and Other Products for the Years 2014, 2024 & 2030
  • Table 65: Germany Recent Past, Current & Future Analysis for Paper Diagnostics by End-Use - Hospitals & Clinics, Home Healthcare and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 66: Germany Historic Review for Paper Diagnostics by End-Use - Hospitals & Clinics, Home Healthcare and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 67: Germany 16-Year Perspective for Paper Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Healthcare and Other End-Uses for the Years 2014, 2024 & 2030
ITALY
  • Table 68: Italy Recent Past, Current & Future Analysis for Paper Diagnostics by Product - Lateral Flow Assay Kits, Dipsticks and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 69: Italy Historic Review for Paper Diagnostics by Product - Lateral Flow Assay Kits, Dipsticks and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 70: Italy 16-Year Perspective for Paper Diagnostics by Product - Percentage Breakdown of Value Sales for Lateral Flow Assay Kits, Dipsticks and Other Products for the Years 2014, 2024 & 2030
  • Table 71: Italy Recent Past, Current & Future Analysis for Paper Diagnostics by End-Use - Hospitals & Clinics, Home Healthcare and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 72: Italy Historic Review for Paper Diagnostics by End-Use - Hospitals & Clinics, Home Healthcare and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 73: Italy 16-Year Perspective for Paper Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Healthcare and Other End-Uses for the Years 2014, 2024 & 2030
UNITED KINGDOM
  • Paper Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
  • Table 74: UK Recent Past, Current & Future Analysis for Paper Diagnostics by Product - Lateral Flow Assay Kits, Dipsticks and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 75: UK Historic Review for Paper Diagnostics by Product - Lateral Flow Assay Kits, Dipsticks and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 76: UK 16-Year Perspective for Paper Diagnostics by Product - Percentage Breakdown of Value Sales for Lateral Flow Assay Kits, Dipsticks and Other Products for the Years 2014, 2024 & 2030
  • Table 77: UK Recent Past, Current & Future Analysis for Paper Diagnostics by End-Use - Hospitals & Clinics, Home Healthcare and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 78: UK Historic Review for Paper Diagnostics by End-Use - Hospitals & Clinics, Home Healthcare and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 79: UK 16-Year Perspective for Paper Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Healthcare and Other End-Uses for the Years 2014, 2024 & 2030
REST OF EUROPE
  • Table 80: Rest of Europe Recent Past, Current & Future Analysis for Paper Diagnostics by Product - Lateral Flow Assay Kits, Dipsticks and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 81: Rest of Europe Historic Review for Paper Diagnostics by Product - Lateral Flow Assay Kits, Dipsticks and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 82: Rest of Europe 16-Year Perspective for Paper Diagnostics by Product - Percentage Breakdown of Value Sales for Lateral Flow Assay Kits, Dipsticks and Other Products for the Years 2014, 2024 & 2030
  • Table 83: Rest of Europe Recent Past, Current & Future Analysis for Paper Diagnostics by End-Use - Hospitals & Clinics, Home Healthcare and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 84: Rest of Europe Historic Review for Paper Diagnostics by End-Use - Hospitals & Clinics, Home Healthcare and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 85: Rest of Europe 16-Year Perspective for Paper Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Healthcare and Other End-Uses for the Years 2014, 2024 & 2030
ASIA-PACIFIC
  • Paper Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
  • Table 86: Asia-Pacific Recent Past, Current & Future Analysis for Paper Diagnostics by Product - Lateral Flow Assay Kits, Dipsticks and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 87: Asia-Pacific Historic Review for Paper Diagnostics by Product - Lateral Flow Assay Kits, Dipsticks and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 88: Asia-Pacific 16-Year Perspective for Paper Diagnostics by Product - Percentage Breakdown of Value Sales for Lateral Flow Assay Kits, Dipsticks and Other Products for the Years 2014, 2024 & 2030
  • Table 89: Asia-Pacific Recent Past, Current & Future Analysis for Paper Diagnostics by End-Use - Hospitals & Clinics, Home Healthcare and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 90: Asia-Pacific Historic Review for Paper Diagnostics by End-Use - Hospitals & Clinics, Home Healthcare and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 91: Asia-Pacific 16-Year Perspective for Paper Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Healthcare and Other End-Uses for the Years 2014, 2024 & 2030
REST OF WORLD
  • Table 92: Rest of World Recent Past, Current & Future Analysis for Paper Diagnostics by Product - Lateral Flow Assay Kits, Dipsticks and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 93: Rest of World Historic Review for Paper Diagnostics by Product - Lateral Flow Assay Kits, Dipsticks and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 94: Rest of World 16-Year Perspective for Paper Diagnostics by Product - Percentage Breakdown of Value Sales for Lateral Flow Assay Kits, Dipsticks and Other Products for the Years 2014, 2024 & 2030
  • Table 95: Rest of World Recent Past, Current & Future Analysis for Paper Diagnostics by End-Use - Hospitals & Clinics, Home Healthcare and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 96: Rest of World Historic Review for Paper Diagnostics by End-Use - Hospitals & Clinics, Home Healthcare and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 97: Rest of World 16-Year Perspective for Paper Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Healthcare and Other End-Uses for the Years 2014, 2024 & 2030
IV. COMPETITION

Companies Mentioned

  • Abcam PLC
  • Abingdon Health Ltd.
  • Acon Laboratories, Inc.
  • Alere, Inc.
  • Arkray, Inc.
  • BBI Solutions
  • Bioporto Diagnostics A/S
  • Bio-Rad Laboratories, Inc.
  • Chembio Diagnostic Systems, Inc.
  • Cytodiagnostics Inc.
  • DCN Diagnostics
  • MilliporeSigma
  • NanoHybrids
  • SD Biosensor, Inc.
  • Siemens Healthineers
  • SurModics, Inc.

Table Information